Eaton Vance Management Royalty Pharma PLC Call Options Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RPRX
# of Institutions
394Shares Held
275MCall Options Held
276KPut Options Held
236K-
Morgan Stanley New York, NY44.2MShares$1.16 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.7MShares$987 Million0.02% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$555 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$436 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$301 Million1.33% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...